SCHEDULE 13G

Statement of Beneficial Ownership

Compass Therapeutics, Inc. Filed 2025-01-16 Acc 0001214659-25-000855

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-02-04 SCHEDULE 13G Statement of Beneficial Ownership
2025-01-16 SCHEDULE 13G Statement of Beneficial Ownership
2025-01-13 4 CEO gave up 58,054 shares (to pay taxes)

Link to a passage

External

SEC EDGAR (opens in new tab)